We are live on ! Find out more
PM

Penbrook Management Portfolio holdings

AUM $157M
1-Year Est. Return 46.57%
This Fund
S&P 500
This Quarter Est. Return
+24.85%
1 Year Est. Return
+46.57%
3 Year Est. Return
+105.97%
5 Year Est. Return
+154.18%
10 Year Est. Return
–
AUM
$157M
AUM Growth
+$24.7M
Cap. Flow
-$334K
Cap. Flow %
-0.21%
Top 10 Hldgs %
45.13%
Holding
104
New
11
Increased
18
Reduced
23
Closed
3

Top Buys

Rank Stock Value
1
ALLT icon
Allot
ALLT
+$2.05M
2
BTE icon
Baytex Energy
BTE
+$1.84M
3
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$473K
4
SA
Seabridge Gold
SA
+$449K
5
BLFS icon
BioLife Solutions
BLFS
+$387K

Top Sells

Rank Stock Value
1
AEHR icon
Aehr Test Systems
AEHR
+$6.79M
2
PL icon
Planet Labs
PL
+$889K
3
PLAB icon
Photronics
PLAB
+$325K
4
XOM icon
ExxonMobil
XOM
+$217K
5
NKE icon
Nike
NKE
+$209K

Sector Composition

Rank Sector Weight
1 Technology 24.86%
2 Healthcare 17.25%
3 Communication Services 15.32%
4 Energy 9.9%
5 Consumer Discretionary 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMPL icon
76
Amplitude
AMPL
$1.63B
$373K 0.24%
+48,705
New +$336K
RITM icon
77
Rithm Capital
RITM
$5.62B
$368K 0.23%
+39,200
New +$374K
IBM icon
78
IBM
IBM
$221B
$361K 0.23%
1,283
– –
RSP icon
79
Invesco S&P 500 Equal Weight ETF
RSP
$99.7B
$355K 0.23%
1,670
– –
TTI icon
80
TETRA Technologies
TTI
$1.02B
$298K 0.19%
26,260
-150
-0.6% -$1.47K
TER icon
81
Teradyne
TER
$55.5B
$290K 0.19%
+600
New +$226K
SPYM
82
State Street SPDR Portfolio S&P 500 ETF
SPYM
$172B
$270K 0.17%
3,075
-105
-3% -$8.96K
IOVA icon
83
Iovance Biotherapeutics
IOVA
$4.03B
$258K 0.16%
61,945
+19,500
+46% +$74.1K
UTG icon
84
Reaves Utility Income Fund
UTG
$3.53B
$249K 0.16%
6,125
– –
WLY icon
85
John Wiley & Sons Class A
WLY
$2.39B
$243K 0.15%
+5,000
New +$210K
JEPI icon
86
JPMorgan Equity Premium Income ETF
JEPI
$45.9B
$239K 0.15%
4,225
– –
GBDC icon
87
Golub Capital BDC
GBDC
$3.38B
$233K 0.15%
18,060
+3,380
+23% +$44K
CVX icon
88
Chevron
CVX
$410B
$228K 0.15%
1,377
– –
AM icon
89
Antero Midstream
AM
$10.7B
$225K 0.14%
9,900
– –
MRK icon
90
Merck
MRK
$372B
$218K 0.14%
1,700
– –
JPM icon
91
JPMorgan Chase
JPM
$947B
$216K 0.14%
+660
New +$205K
COP icon
92
ConocoPhillips
COP
$162B
$211K 0.13%
2,025
– –
FAF icon
93
First American
FAF
$7.64B
$206K 0.13%
+3,000
New +$200K
VKQ icon
94
Invesco Municipal Trust
VKQ
$530M
$201K 0.13%
20,000
– –
SKYH icon
95
Sky Harbour Group
SKYH
$412M
$192K 0.12%
+19,530
New +$191K
BNED icon
96
Barnes & Noble Education
BNED
$430M
$188K 0.12%
+15,000
New +$157K
NUV icon
97
Nuveen Municipal Value Fund
NUV
$1.86B
$184K 0.12%
20,000
– –
AQST icon
98
Aquestive Therapeutics
AQST
$680M
$180K 0.11%
43,300
+17,735
+69% +$74.6K
DX
99
Dynex Capital
DX
$3.2B
$132K 0.08%
10,050
– –
ONDS icon
100
Ondas Inc
ONDS
$4.3B
$82.4K 0.05%
10,005
– –
1 2 3
4
5

Similar funds

AFW
Avantra Family Wealth Mechanicsburg, Pennsylvania $157M AUM 35.53% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $157M AUM 29.28% 1-Year Est. Return
AWA
Authentikos Wealth Advisory Morgan Hill, California $157M AUM 21.34% 1-Year Est. Return
BGAI
Bruce G. Allen Investments Denver, Colorado $157M AUM 28.14% 1-Year Est. Return
AIG
Abbington Investment Group Westport, Connecticut $157M AUM 35.92% 1-Year Est. Return
MFG
Mosaic Financial Group Chicago, Illinois $156M AUM 23.77% 1-Year Est. Return
BCM
Bayesian Capital Management Brooklyn, New York $156M AUM 14.89% 1-Year Est. Return
MCM
Mork Capital Management Healdsburg, California $156M AUM 39.85% 1-Year Est. Return

Penbrook Management's Q2 2026 Portfolio in Review

As of Q2 2026, Penbrook Management held 104 positions worth $157M, up 19% from $132M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Penbrook Management's Q2 2026 filing shows 11 new, 18 increased, 23 reduced and 3 closed positions. Its largest new stake was Allot: 275,295 shares worth $2.44M. The largest sale was Aehr Test Systems, an estimated $6.79M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Communication Services.

  • Penbrook Management's largest Q2 2026 buy was Allot: 275,295 shares worth $2.44M.
  • Penbrook Management added most to Seabridge Gold in Q2 2026, an estimated $449K increase.
  • Penbrook Management's biggest Q2 2026 reduction was Aehr Test Systems, cutting an estimated $6.79M.
  • Penbrook Management fully exited ExxonMobil in Q2 2026, selling an estimated $217K.
  • Penbrook Management's ten largest holdings make up 45% of its $157M portfolio in Q2 2026.
  • Penbrook Management opened 11 new positions and closed 3 in Q2 2026.
  • Penbrook Management's portfolio value rose 19% quarter-over-quarter to $157M.

Based on Penbrook Management's 13F filing for Q2 2026, filed 23 Jul 2026.